Mayne Pharma Submits New Drug Application for E4/DRSP to the FDA

ADELAIDE, Australia and LIEGE, Belgium, April 16, 2020 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) and Mithra Pharmaceuticals, SA (Euronext Brussels: MITRA) today announced that Mayne Pharma has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA),...

from PR Newswire: https://ift.tt/2wIOlQx